Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21134808 | 1.00 | ANPEP (0.38) | ANPEPENPEPOPRD1OPRK1 | |
| SCHEMBL21135255 | 1.00 | ANPEP (0.38) | ANPEPENPEPOPRD1OPRK1 | |
| SCHEMBL19934737 | 1.00 | ANPEP (0.38) | ANPEPENPEPOPRD1OPRK1 | |
| SCHEMBL19934642 | 1.00 | ANPEP (0.38) | ANPEPENPEPOPRD1OPRK1 | |
| SCHEMBL28678248 | 1.00 | ANPEP (0.38) | ANPEPENPEPOPRD1OPRK1 | |
| SCHEMBL21134702 | 1.00 | ANPEP (0.38) | ANPEPENPEPOPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL21084904 | 0.98 | ANPEP (0.36) | ANPEPENPEPOPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL21084965 | 0.98 | ANPEP (0.36) | ANPEPENPEPOPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL21084943 | 0.98 | ANPEP (0.36) | ANPEPENPEPOPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL21084942 | 0.98 | ANPEP (0.36) | ANPEPENPEPOPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11008286-B2 | Amino mercaptan compound and preparation method therefor and use thereof in protection against radiation | SHANGHAI KECHOW PHARMA, INC (CN) | 2021-05-18 | — | — | US | disclosed |
| EP-3508476-A1 | AMINO MERCAPTAN COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PROTECTION AGAINST RADIATION | Inst Of Radiation Medicine Chinese Acad Of Medical Sciences (CN) | 2019-07-10 | — | — | EP | disclosed |
| US-20190202779-A1 | AMINO MERCAPTAN COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PROTECTION AGAINST RADIATION | SHANGHAI KECHOW PHARMA, INC. (CN) | 2019-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190202779-A1 | AMINO MERCAPTAN COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PROTECTION AGAINST RADIATION | MGMT, PRMT8, SULT1A1 | ANPEP 2983/4885ENPEP 2353/4885OPRD1 936/4885 |
| US-11008286-B2 | Amino mercaptan compound and preparation method therefor and use thereof in protection against radiation | MGMT, GSTA1, PRMT1 | ANPEP 737/4885ENPEP 540/4885OPRD1 1603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.